Abstract:Background: Pericytes are crucial for the development, stabilization, and functional regulation of microvasculature, especially in the retina. In diabetic retinopathy (DR), early loss of pericytes is a key event that drives microvascular dysfunction. Despite their critical role, the mechanisms underlying the functional heterogeneity of pericytes in DR remain poorly understood, impeding the development of effective therapeutic strategies. Methods: We employed single-cell RNA sequencing to construct a comprehensive single-cell atlas of non-diabetic and diabetic retinas. Using bioinformatic clustering and subcluster analysis, we identified a specific pericyte subcluster associated with diabetic microvascular complications. Differential gene expression analysis and immunofluorescence validation highlighted PTTG1 as a potential key regulator of pericyte dysfunction. To investigate its functional role, we emplyed CRISPR/Cas9 and adenoviral vectors to modulate PTTG1 expression in vitro and in vivo. Combined transcriptomic and metabolomic approaches were used to explore the mechanistic pathways through which PTTG1 influences pericyte biology and vascular function. Results: We identified a novel pericyte subcluster characterized by elevated expression of PTTG1, which was strongly correlated with diabetic microvascular dysfunction. Silencing PTTG1 using CRISPR/Cas9 and siRNA in vitro mitigated pericyte dysfunction under high-glucose conditions. Targeted knockdown of PTTG1 using viral vectors improved retinal vascular integrity and reduced neovascularization in diabetic mice. Transcriptomic and untargeted metabolomic analyses revealed that PTTG1 knockdown reprogrammed pericyte energy metabolism by modulating glycolysis pathway genes, reducing oxidative stress, and restoring pericyte function, ultimately alleviating microvascular dysfunction in DR. Conclusions: PTTG1 plays a critical role in regulating pericyte dysfunction and maintaining vascular homeostasis in diabetic retinopathy. By modulating key metabolic pathways and pericyte phenotypes, PTTG1 represents a promising therapeutic target for treating diabetic microvascular complications. These insights offer a novel molecular framework for developing targeted therapies aimed at restoring retinal vascular health in diabetic patients.

Role of Pericytes in Mechanisms of Diabetic Retinopathy

Inflammatory Machenism in the Pathogenesis of Diabetic Retinopathy

Pericytes and the Pathogenesis of Diabetic Retinopathy

Targeting pericyte retention in Diabetic Retinopathy: a review

Pericyte in retinal vascular diseases: A multifunctional regulator and potential therapeutic target

The pathophysiological mechanisms underlying diabetic retinopathy

Pericyte Bridges in Homeostasis and Hyperglycemia: Reconsidering Pericyte Dropout and Microvascular Structures

Pericyte Bridges in Homeostasis and Hyperglycemia

PTTG1-Mediated Pericyte Dysfunction Drives Diabetes-Induced Microvascular Dysfunction

An overview of the pathogenesis of diabetic retinopathy

The role of pericyte in ocular vascular diseases

Molecules related to diabetic retinopathy in the vitreous and involved pathways

The Protective Role of Apelin in the Early Stages of Diabetic Retinopathy

Diabetic retinopathy: Involved cells, biomarkers, and treatments

RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy

Glucose transport, transporters and metabolism in diabetic retinopathy

Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy

Lymphatic Vascular Structures: A New Aspect in Proliferative Diabetic Retinopathy

Endothelial progenitor cells in diabetic retinopathy

Prostaglandin F2α protects against pericyte apoptosis by inhibiting the PI3K/Akt/GSK3β/β-catenin signaling pathway

Emerging role of extracellular vesicles in diabetic retinopathy